Bupropion Tablets and Sustained-Release Tablets and Dihydroergotamine Mesylate
Determining the interaction of Bupropion Tablets and Sustained-Release Tablets and Dihydroergotamine Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion Tablets and Sustained-Release Tablets-Dihydroergotamine nasal
- Bupropion Tablets and Sustained-Release Tablets-Dihydroergotamine Nasal Spray
- Bupropion Tablets and Sustained-Release Tablets-Dilacor XR
- Bupropion Tablets and Sustained-Release Tablets-Dilantin
- Bupropion Tablets and Sustained-Release Tablets-Dilantin Infatabs
- Bupropion Tablets and Sustained-Release Tablets-Dilantin injection
- Dihydroergotamine Mesylate-Burapren Injection
- Dihydroergotamine Mesylate-Burn-O-Jel Topical application
- Dihydroergotamine Mesylate-Burnamycin Topical application
- Dihydroergotamine Mesylate-Burosumab
- Dihydroergotamine Mesylate-Burosumab-twza
- Dihydroergotamine Mesylate-Burosumab-twza Subcutaneous